Roth Vision Care

Roth Vision Care Enhancing your quality of life through better visual care. We sincerely care for individuals from all walks of life with diverse visual needs.

Roth Vision Care is an eye care facility dedicated to rendering the most advanced and comprehensive level of optometric care available. Our mission is to provide each individual patient with our highest quality of care, by maintaining state-of-the-art instrumentation, with our commitment to continuing education, and through our respect and concern for each patients visual wellness and satisfaction. We respect each and every patient, and realize you have a choice when it comes to who provides for the visual needs for yourself and your family. Our comprehensive experience allows us to treat a myriad of ocular diseases, as well as provide refractive options such as glasses, orthokeratology, contact lenses, and refractive co-management. Education Videos
http://statictab.com/9mzy6qd

New Patients
http://statictab.com/p4qdijj

Existing Patients
http://statictab.com/rhf8gao

New treatment for dry macular degeneration!!Results: A total of 148 eyes (100 subjects) with dry AMD were randomized int...
03/14/2026

New treatment for dry macular degeneration!!

Results:
A total of 148 eyes (100 subjects) with dry AMD were randomized into the study. LIGHTSITE III met the prespecified primary BCVA efficacy endpoint at M21 with a significant difference between treatment groups (p = 0.0036) and a +6.2 letter gain following PBM. At M21, 61.5% of PBM-treated eyes showed ≥5, 23.1% showed ≥10, and 4.4% showed ≥15 letter gains. A favorable safety profile was observed with no signs of phototoxicity. Disease progression to Geographic Atrophy (GA) showed a significant decrease in incidence (Sham, 24.0% vs. PBM, 6.8%; p = 0.007) following PBM treatment at M24. Significant benefit in vision QoL was observed.

Conclusions:
Multiwavelength PBM represents an interventional therapy that restores visual function and has potential disease-modifying effects in intermediate dry AMD.

02/21/2026

New research is challenging our thoughts regarding why children become near sighted.



Myopia Study Proposes a New Explanation for Why Near Work and Low Light May Drive Nearsightedness

New York, NY — For years, rising rates of myopia — or nearsightedness — have been widely attributed to increased screen time, especially among children and young adults. But new research from scientists at the SUNY College of Optometry suggests the story may be more complicated — and more human.

In a new study published in Cell Reports, researchers propose that myopia may be driven less by screens themselves and more by a common indoor visual habit: prolonged close-up focus in low-light environments, which limits how much light reaches the retina.

…….

So we may need to tell our kids hold things further back and turn on the lights!

10/22/2025

Macular degeneration treatment. The future can be exciting!

08/06/2025

From epocrates: More evidence that GLP-1 RA use ups the risk of optic nerve damage

Most people actually have this, and it’s benign. We only need to treat it if there are symptoms However, knowledge is po...
07/14/2025

Most people actually have this, and it’s benign. We only need to treat it if there are symptoms
However, knowledge is power

There’s a scarier, overlooked cause of dry eye — microscopic pests living in our eyelashes and eyebrows. 👀

06/05/2025

👁️ Scientists 3D-printed the first human corneas using a bio-ink made from stem cells!

The process takes just 10 minutes and can be customized for each patient, providing a way to restore sight to millions worldwide.

Researchers at Newcastle University have successfully 3D-printed the first human corneas using stem cells and a specially developed bio-ink.

This innovation offers a promising solution to the global shortage of donor corneas, with over 10 million people worldwide requiring surgery to prevent blindness caused by diseases like trachoma, and nearly 5 million already blind due to corneal scarring.

Using a low-cost 3D printer, the team extruded a stem cell-infused gel made from alginate and collagen to form a cornea in under 10 minutes — a process that maintained cell viability and shape fidelity.

The study, published in Experimental Eye Research, showed that corneas can be custom-printed to fit individual patients by scanning their eyes and using the data to shape the tissue. While the technology still requires years of testing before it can be used in transplants, experts say it holds enormous potential.

“This approach has the potential to combat the worldwide shortage,” said Professor Che Connon, who led the study. Until then, researchers stress that organ donation remains essential for those suffering from corneal blindness today.

05/26/2025
Recall alertWe at Roth Vision Care don’t recommend any of these drops, but if you happened to buy them
05/13/2025

Recall alert

We at Roth Vision Care don’t recommend any of these drops, but if you happened to buy them

The FDA and AvKare have reported a recall of eye care products, including drops and artificial tears, from BRS Analytical Service.

This investigation through clinical studies is still new. People are reporting Ischemic optic neuropathy, a stoke to the...
04/30/2025

This investigation through clinical studies is still new. People are reporting Ischemic optic neuropathy, a stoke to the nerve of the eye, which can have devastating visual consequences. Appears to be a low risk, and definite association is still trying to be determined, but users should be aware there is a potential risk.

Eyelid eczema
04/28/2025

Eyelid eczema

Address

725 Erie Boulevard W
Syracuse, NY
13204

Opening Hours

Monday 8am - 5:30pm
Tuesday 8am - 2pm
Wednesday 8am - 5:30pm
Thursday 9am - 1pm
Friday 8am - 1pm

Telephone

+13154752778

Alerts

Be the first to know and let us send you an email when Roth Vision Care posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Roth Vision Care:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram